iBio (IBIO) Earnings Date & Reports

iBio Inc is a clinical-stage biotechnology company using Artificial Intelligence (AI) for the development of hard-to-drug precision antibodies for obesity, cardiometabolic, and cardiopulmonary diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

IBIO is expected to report earnings to fall 8.86% to -6 cents per share on September 29

Q2'26

Est.

$-0.06

Q1'26

Beat

by $0.13

Q4'25

Beat

by $0.34

Q3'25

Beat

by $0.14

Q2'25

Missed

by $0.12

The last earnings report on May 12 showed earnings per share of -7 cents, beating the estimate of -20 cents. With 122.54K shares outstanding, the current market capitalization sits at 77.49M.

View a ticker or compare two or three

IBIO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for IBIO